Tertiapin LQ is a modified bee venom peptide with characteristic disulfide bonds that stabilize its compact scaffold. Residue substitutions modulate binding affinity toward selected ion channels. Researchers study its structure through NMR and electrophysiology to map channel-interaction determinants. Applications include toxin engineering, channel-selectivity research, and disulfide-rich scaffold exploration.
Tertiapin LQ is a synthetic peptide derivative originally inspired by a naturally occurring peptide from honey bee venom, recognized for its selective inhibition of specific inward-rectifier potassium channels. As a member of the peptide toxin family, it is engineered to possess enhanced stability and defined sequence characteristics, making it a valuable tool in ion channel research. Its distinctive ability to modulate the activity of Kir1.1 and Kir3.x (GIRK) channels has established its significance in studies of cellular electrophysiology, signal transduction, and the physiological roles of potassium channels in various tissues. The peptide's well-characterized structure and mechanism of action support its use in advanced research settings, including functional studies and pharmacological profiling.
Ion Channel Research: Tertiapin LQ is widely utilized as a selective probe for dissecting the function of inward-rectifier potassium channels, particularly the Kir1.1 and GIRK subfamilies. By blocking these channels with high specificity, it enables researchers to investigate their physiological contributions to membrane potential regulation, cellular excitability, and signal integration in neurons, cardiomyocytes, and epithelial cells. Its application facilitates the detailed mapping of channel distribution and function, advancing understanding of ion channelopathies and the molecular underpinnings of electrical signaling.
Electrophysiological Studies: The peptide's potent and selective channel-blocking activity makes it an essential reagent in patch-clamp experiments and other electrophysiological assays. When applied to isolated cells or tissue preparations, it provides a precise means to isolate the currents mediated by Kir channels, allowing for quantitative assessment of channel kinetics, conductance properties, and pharmacological modulation. This capacity is crucial for elucidating the biophysical properties of potassium channels and for validating the effects of experimental interventions.
Pharmacological Screening: In drug discovery and safety pharmacology, Tertiapin LQ serves as a reference inhibitor for evaluating the selectivity and efficacy of candidate molecules targeting inward-rectifier potassium channels. Its defined activity profile supports the benchmarking of novel compounds, aiding in the identification of off-target effects and the characterization of channel subtype-specific interactions. By providing a reliable standard, it streamlines the screening process for new modulators and supports the development of more selective ion channel therapeutics.
Peptide Structure-Function Analysis: The engineered sequence of Tertiapin LQ offers a platform for exploring the structural determinants of peptide-channel interactions. Through site-directed mutagenesis and analog synthesis, researchers can systematically modify the peptide to probe the roles of specific amino acid residues in binding affinity and selectivity. Such studies contribute to the broader understanding of protein-peptide recognition and inform the rational design of next-generation ion channel modulators.
Neuroscience and Signal Transduction Research: By modulating GIRK channel activity, Tertiapin LQ is instrumental in studies examining the role of potassium channels in synaptic transmission, neuronal excitability, and neurotransmitter signaling. Its application enables the dissection of GIRK-mediated pathways in both central and peripheral nervous systems, providing insights into the cellular mechanisms that govern neural circuit function and adaptation. This utility supports investigations into the basic biology of neural signaling as well as the pathophysiological basis of channel-related disorders.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More